U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
190771190771ACE Inhibition and Novel Cardiovascular Risk FactorsCompletedNo Results AvailableCardiovascular Diseases|Heart Diseases|HypertensionDrug: Fosinoprilhttps://ClinicalTrials.gov/show/NCT00051389
190772190772Vascular Interaction With Age in Myocardial InfarctionCompletedNo Results AvailableMyocardial InfarctionDrug: L-Argininehttps://ClinicalTrials.gov/show/NCT00051376
190773190773Apnea Positive Pressure Long-Term Efficacy StudyCompletedNo Results AvailableLung Diseases|Sleep Apnea Syndromes|SleepDevice: Positive Pressure Respiration|Device: Sham CPAP machinehttps://ClinicalTrials.gov/show/NCT00051363
190774190774OmniHeart Trial: Macronutrients and Cardiovascular RiskCompletedNo Results AvailableCardiovascular Diseases|Heart Diseases|Atherosclerosis|HypertensionBehavioral: Diet therapyhttps://ClinicalTrials.gov/show/NCT00051350
190775190775Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement DisordersCompletedNo Results AvailableHyperkinesishttps://ClinicalTrials.gov/show/NCT00051337
190776190776Neurobiological Predictors of Huntington's Disease (PREDICT-HD)RecruitingNo Results AvailableHuntington Diseasehttps://ClinicalTrials.gov/show/NCT00051324
190777190777Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System CancersCompletedNo Results AvailableHematologic NeoplasmsProcedure: Stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00051311
190778190778Olanzapine Versus Placebo in the Treatment of Adolescents With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Olanzapine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00051298
190779190779ESSENTIAL-"The Studies of Oral Enoximone Therapy in Advanced Heart Failure"TerminatedNo Results AvailableHeart Failure, CongestiveDrug: Enoximone|Drug: Enoximone placebohttps://ClinicalTrials.gov/show/NCT00051285
190780190780Effects Of Antidepressants On Sexual Functioning In AdultsCompletedNo Results AvailableMajor Depressive Disorder (MDD)Drug: Extended-release Bupropion Hydrochloridehttps://ClinicalTrials.gov/show/NCT00051272
190781190781Effects of Antidepressants on Sexual FunctioningCompletedNo Results AvailableMajor Depressive Disorder (MDD)Drug: Extended-Release Bupropion Hydrochloridehttps://ClinicalTrials.gov/show/NCT00051259
190782190782Group Therapy for Postpartum DepressionCompletedNo Results AvailableDepression, PostpartumBehavioral: Mother-Infant Group Psychotherapy|Behavioral: Interpersonal Psychotherapyhttps://ClinicalTrials.gov/show/NCT00051246
190783190783Treatment of Schizophrenia Through Internet-Based PsychoeducationCompletedNo Results AvailableSchizophrenia|Schizoaffective DisorderProcedure: World Wide Web-Based Psychoeducationhttps://ClinicalTrials.gov/show/NCT00051233
190784190784Treatment for Specific Phobias in ChildrenCompletedNo Results AvailablePhobic Disorders|Anxiety DisordersBehavioral: One-Session Treatment for Specific Phobiashttps://ClinicalTrials.gov/show/NCT00051220
190785190785Therapy for Depression With Co-occurring Panic or Anxiety SymptomsCompletedNo Results AvailableDepression|Anxiety Disorders|Panic DisorderBehavioral: Interpersonal Psychotherapy (IPT)|Behavioral: IPT for Depression with Co-occurring Panic and Anxiety Symptoms (IPT-PS)https://ClinicalTrials.gov/show/NCT00051207
190786190786A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular HypertensionCompletedNo Results AvailableGlaucoma, Open-angle|Ocular HypertensionDrug: Combination IOP Lowering Therapyhttps://ClinicalTrials.gov/show/NCT00051194
190787190787A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure GlaucomaCompletedNo Results AvailableGlaucoma, Angle-Closure|Ocular HypertensionDrug: Travoprost (0.004%)|Drug: Latanoprost (0.005%)https://ClinicalTrials.gov/show/NCT00051181
190788190788A Long-term Safety Study of Once-daily TravatanCompletedHas ResultsGlaucoma, Open-angle|Ocular HypertensionDrug: Travatanhttps://ClinicalTrials.gov/show/NCT00051168
190789190789A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)CompletedNo Results AvailableGlaucoma, Open-Angle|Ocular HypertensionDrug: Travoprost (0.004%)|Drug: Latanoprost (0.005%)/Timolol (0.5%)https://ClinicalTrials.gov/show/NCT00051155
190790190790A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)CompletedNo Results AvailableGlaucoma, Open-Angle|Ocular HypertensionDrug: Travoprost|Drug: Latanoprosthttps://ClinicalTrials.gov/show/NCT00051142
190791190791Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)CompletedNo Results AvailableMacular Degeneration|Maculopathy, Age-Related|Age-Related Maculopathies|Age-Related Maculopathy|Maculopathies, Age-RelatedDrug: Anecortave Acetate 15 mg sterile suspension|Other: Anecortave Acetate Vehiclehttps://ClinicalTrials.gov/show/NCT00051129
190792190792A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple MyelomaCompletedNo Results AvailableMultiple MyelomaDrug: CC-5013https://ClinicalTrials.gov/show/NCT00051116
190793190793Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.CompletedNo Results AvailableMetastatic Breast Cancer|Neoplasms, BreastDrug: Investigational Cancer Drughttps://ClinicalTrials.gov/show/NCT00051103
190794190794Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIVWithdrawnNo Results AvailableHIV Infections|Hepatitis BDrug: Telbivudine|Drug: Lamivudine|Drug: Efavirenz|Drug: Didanosine|Drug: Abacavirhttps://ClinicalTrials.gov/show/NCT00051090
190795190795Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)WithdrawnNo Results AvailableHIV Infections|Hepatitis B|Hepatitis CDrug: Adefovir dipivoxil|Drug: Peginterferon-alfa-2A|Drug: Ribavirin|Procedure: Liver Biopsyhttps://ClinicalTrials.gov/show/NCT00051077
190796190796A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast CancerCompletedNo Results AvailableBreast NeoplasmsDrug: CI-1033https://ClinicalTrials.gov/show/NCT00051051
190797190797Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected PatientsCompletedNo Results AvailableHepatitis BDrug: Entecavirhttps://ClinicalTrials.gov/show/NCT00051038
190798190798Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)CompletedHas ResultsNon-Hodgkin's Lymphoma|Lymphoma, B-cell|Lymphoma, Low-gradeDrug: ONTAKhttps://ClinicalTrials.gov/show/NCT00051025
190799190799Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma PatientsCompletedNo Results AvailableLymphoma, T-Cell, Cutaneous|Mycosis Fungoides|Sezary SyndromeDrug: ONTAKhttps://ClinicalTrials.gov/show/NCT00051012
190800190800Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) PatientsCompletedNo Results AvailableLymphoma, T-Cell, Cutaneous|Mycosis Fungoides|Sezary SyndromeDrug: ONTAKhttps://ClinicalTrials.gov/show/NCT00050999

* Görseller ve İçerik tekif hakkına sahip olabilir